Biogen

Anonymous board for Biogen
Post thread
FDA delays Biogen's ALS drug review by three months, decision to now come next April-Endpoints News
Replies
6
Views
2K
anonymous
Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal | Fierce Biotech
Replies
18
Views
3K
anonymous
Axios: New Alzheimer's drug faces uncertain regulatory path
Replies
1
Views
777
anonymous
Eisai's Alzheimer's hopeful lecanemab may have contributed to patient death: report | Fierce Biotech
Replies
8
Views
2K
anonymous
Compensation Transparency
Replies
0
Views
2K
anonymous
Salary
Replies
2
Views
2K
anonymous
Where did Deb land?
Replies
26
Views
10K
anonymous
Zuranolone
Replies
0
Views
2K
anonymous
STAT: It’s Eisai, not Biogen, pulling the strings on lecanemab
Replies
0
Views
915
anonymous
Biogen insists Eisai relationship 'solid' as questions remain over lecanemab commercialization | Fie
Replies
0
Views
682
anonymous
Mathai Mammen emerges as top candidate for Biogen CEO job — STAT
Replies
7
Views
4K
anonymous
Alisha Cares!
Replies
4
Views
3K
anonymous
The sequel
Replies
25
Views
5K
anonymous
Eisai And Biogen: Only APOE4 Carriers Benefit From Lecanemab | Seeking Alpha
Replies
1
Views
1K
anonymous
$0 bonuses GoFundMe
Replies
1
Views
1K
anonymous
Biogen's push to regain Tecfidera patent swatted down by SCOTUS
Replies
1
Views
850
anonymous
Biogen throws itself back into muddled data arguments with more details on its antisense ALS drug –
Replies
2
Views
1K
anonymous
Biogen pays $900M to resolve whistleblower's kickbacks suit
Replies
40
Views
9K
anonymous
Are you proud to have a job AT Biogen?
Replies
8
Views
3K
anonymous
We’ve lost our lease! Everything must go!
Replies
3
Views
2K
anonymous
Top Bottom
Back
Post thread